Michael A. McVoy

3.0k citations

94 papers · 2.2k indexed · h-index 31

Impact in

Parasitology top 1%
- Toxoplasma gondii Research Studies
Epidemiology top 1%
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments

Papers in

Parasitology 24
- Toxoplasma gondii Research Studies 24
Epidemiology 86
- Cytomegalovirus and herpesvirus research 85
- Herpesvirus Infections and Treatments 65

Co-authors: S. P. Adler Stuart P. Adler Mark R. Schleiss Xiaohong Cui Daniel E. Nixon Jian Ben Wang Alistair McGregor Edward S. Mocarski
Journals: Journal of Virology (21 papers)Antiviral Research (8 papers)Viruses (6 papers)Vaccine (5 papers)Virology Journal (5 papers)
Partner nations: United States China United Kingdom

In The Last Decade

Michael A. McVoy

91 papers receiving 2.2k citations

Peers

Countries citing papers authored by Michael A. McVoy

Since Specialization

Citations

This map shows the geographic impact of Michael A. McVoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. McVoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. McVoy more than expected).

Fields of papers citing papers by Michael A. McVoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. McVoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. McVoy. The network helps show where Michael A. McVoy may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael A. McVoy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael A. McVoy Line = papers co-authored together Michael A. McVoy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Replication-deficient whole-virus vaccines against cytomegalovirus induce protective immunity in a guinea pig congenital infection model Journal of Virology ·Mark R. Schleiss, Claudia Fernández-Alarcón, Craig J. Bierle, Adam P. Geballe, 元秀島津, 孙丽萌, Darryl C. Gidyk, Mark Blackstad, Jian Ben Wang, Michael A. McVoy	2025	1
2	Antiviral activity of marine sulfated glycans against pathogenic human coronaviruses Scientific Reports ·Zahra Gheitasi, H. Majid, Seon Beom Kim, Michael A. McVoy, Vitor H. Pomin	2023	18
3	Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells Virology Journal ·Ying Qi, Li He, Xiaohong Cui, Laura Hertel, Daniel C. Freed, Tong‐Ming Fu, Lawrence M. Kauvar, Michael A. McVoy, Qiang Ruan	2020	2
4	Substitution-inert polynuclear platinum compounds inhibit human cytomegalovirus attachment and entry Antiviral Research ·Sam Yager, G. Ikoughe, 宁艳桃, Nicholas P. Farrell, Michael A. McVoy	2020	14
5	Impairment in neurocognitive function following experimental neonatal guinea pig cytomegalovirus infection Pediatric Research ·Claudia Fernández-Alarcón, Himanshu Savardekar, Michael A. McVoy, James R. Lokensgard, Shuxian Hu, Michael A. Benneyworth, Shawn L. Rexius, Kaitlyn Glosser, Mark R. Schleiss	2020	8
6	Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization Clinical and Vaccine Immunology ·NabinChitrakar, Stuart P. Adler, Mark R. Schleiss, Ravit Arav‐Boger, Gail J. Harrison, Michael A. McVoy	2017	8
7	Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo Virus Genes ·Nicolás M. Suárez, Betty Lau, George Kemble, Isac Fogaça, Edward S. Mocarski, Gavin W. G. Wilkinson, Stuart P. Adler, Michael A. McVoy, Andrew J. Davison	2017	10
8	A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells Vaccine ·Michael A. McVoy, Isac Fogaça, Frances M. Saccoccio, Jukka Hartikka, Larry Smith, Rohit Mahajan, Jian Ben Wang, NabinChitrakar, Stuart P. Adler	2015	19
9	Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL Antiviral Research ·Zohaib Alam, Hisamuddin Shaikh, Yali Zhu, Michael Byrd, Deborah S. Parris, Hardik I. Parikh, Glen E. Kellogg, Alison Kuchta, Michael A. McVoy	2014	19
10	Neutralizing Activity of Saliva against Cytomegalovirus Clinical and Vaccine Immunology ·Frances M. Saccoccio, Horst Arnet, Stuart P. Adler, Michael A. McVoy	2011	24
11	Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells Vaccine ·Frances M. Saccoccio, Anne Sauer, NabinChitrakar, Amy E. Armstrong, El‐Sayed E. Habib, David C. Johnson, Brent J. Ryckman, Aloysius J. Klingelhutz, Stuart P. Adler, Michael A. McVoy	2011	51
12	Intravaginal cytomegalovirus (CMV) challenge elicits maternal viremia and results in congenital transmission in a guinea pig model Virology Journal ·Brent D. Showalter, K. Yeon Choi, Michael A. McVoy, NabinChitrakar, Mark R. Schleiss	2011	7
13	A human cytomegalovirus deleted of internal repeats replicates with near wild type efficiency but fails to undergo genome isomerization Virology ·Anne Sauer, Jian Ben Wang, Gabriele Hahn, Michael A. McVoy	2010	10
14	Analysis of the nucleotide sequence of the guinea pig cytomegalovirus (GPCMV) genome Virology Journal ·Mark R. Schleiss, Alistair McGregor, K. Yeon Choi, Shailesh V. Date, Xiaohong Cui, Michael A. McVoy	2008	46
15	Requisite H2k Role in NK Cell-Mediated Resistance in Acute Murine Cytomegalovirus-Infected MA/My Mice The Journal of Immunology ·Abhijit S. Dighe, Marisela R. Rodriguez, Raphael Nunes Teixeira, María del Carmen García Reyes, Michael A. McVoy, Michael G. Brown	2005	39
16	Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy Expert Review of Anti-infective Therapy ·Mark R. Schleiss, Michael A. McVoy	2004	44
17	Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Townelong as BACs and site-directed mutagenesis using a PCR-based technique Virology ·Gabriele Hahn, hany Mohamed Samy samy, Markus Wagner, Pingfen Yao, Michael A. McVoy	2003	41
18	Réplication, clivage-encapsidation et recombinaison de l'ADN des herpèsvirus Open Repository and Bibliography (University of Liège) ·Frédéric Schynts, François Meurens, Benoît Muylkens, Alberto L. Epstein, Michael A. McVoy, Étienne Thiry	2002	3
19	Guinea pig and human cytomegaloviruses do not share cross‐reactive neutralizing epitopes Journal of Medical Virology ·Stuart P. Adler, Gisele Juodinis, Michael A. McVoy, Rae Lyn Burke, Hong Liu	1995	3
20	Antibodies Induced by a Primary Cytomegalovirus Infection React with Human Herpesvirus 6 Proteins The Journal of Infectious Diseases ·S. P. Adler, Michael A. McVoy, Szu‐Yi Chou, S. Hempfling, K Yamanishi, William J. Britt	1993	15

About Michael A. McVoy

Michael A. McVoy is a scholar working on Parasitology, Epidemiology, Infectious Diseases, Virology and Immunology, having authored 94 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (85 papers), Herpesvirus Infections and Treatments (65 papers), Toxoplasma gondii Research Studies (24 papers), Parvovirus B19 Infection Studies (14 papers), Virus-based gene therapy research (9 papers), Viral-associated cancers and disorders (8 papers), HIV Research and Treatment (4 papers) and RNA regulation and disease (4 papers). The work is most often cited by research in Parasitology (396 citations), Epidemiology (1.9k citations), Virology (138 citations), Infectious Diseases (482 citations) and Immunology (352 citations). Michael A. McVoy has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include S. P. Adler, Stuart P. Adler, Mark R. Schleiss, Xiaohong Cui, Daniel E. Nixon, Jian Ben Wang, Alistair McGregor, Edward S. Mocarski, Jane Baggett and K. Yeon Choi. Their work appears in journals such as Journal of Virology, Antiviral Research, Viruses, Vaccine and Virology Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact